Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Diuretic Drugs Therapy Market: By Product: Thiazide Diuretics Local, Loop Diuretics, Potassium-Sparing Diuretics, Others; By Route of Administration; By Application; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments

Global Diuretic Drugs Therapy Market Outlook

The global diuretic drugs therapy market is being aided by the growing antihypertensive drugs market, which reached a value of about USD 28 billion in 2020. The antihypertensive drugs industry is further expected to grow at a CAGR of 2% in the forecast period of 2021-2026 to reach a value of approximately USD 32 billion by 2026.

 

The Asia Pacific to Significantly Contribute to the Growth of the Global Market for Diuretic Drugs Therapy

North America accounts for a significant share in the industry owing to the availability of advanced diagnostic facilities, increased health care expenditure, and the growing cases of diuretic anomalies and lifestyle related disorders. Meanwhile, the Asia Pacific is expected to witness a robust growth over the forecast period owing to the increasing government initiatives towards patent exclusivity and the growing investments in new drug applications. Further, the factors like the presence of a large population and the growth of the generic drugs market are also aiding the regional industry. Other regions like Europe and the Middle East and Africa are expected to create significant growth opportunities for the market expansion over the forecast period. This can be attributed to the increasing geriatric population in these regions.

 

Diuretic Drugs Therapy: Industry Definition and Segmentation

Diuretic drugs therapy refers to a medical treatment for patients suffering from health conditions like high blood pressure, water retention problems, and heart failure (HF). Diuretics, also known as water pills, are a class of drugs that increase the production and volume of urine by tilting the renal fluid regulation in favour of excretion of water and electrolytes (salt). These drugs are commonly prescribed to treat edema, wherein excess fluid accumulates in the tissues due to various disease states like heart failure, liver cirrhosis, and kidney disease. Diuretics are often used to treat hypertension and regulate blood pressure.

Based on product, the market is divided into:

  • Thiazide Diuretics Local
  • Loop Diuretics
  • Potassium-Sparing Diuretics
  • Calcium Sparing Diuretics
  • Osmotic Diuretics
  • Low Ceiling Diuretics
  • Others

By route of administration, the industry can be bifurcated into:

  • Oral
  • Intravenous

The different applications of diuretic drugs therapy include:

  • Hypertension
  • Glaucoma
  • Heart Failure
  • Kidney Stones
  • Others

On the basis of distribution channel, the industry can be categorised into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Growing Prevalence of High Blood Pressure and Hypertension to Bolster the Growth of the Global Market for Diuretic Drugs Therapy

The increase in the number of people suffering from blood pressure and hypertension is the major factor contributing to the growth of the diuretic drugs therapy industry. Diuretics are used as the chief therapeutic agents to treat hypertension and are generally the first type of medication prescribed by doctors to control blood pressure. According to estimates, worldwide deaths due to high blood pressure are expected to increase from 7.5 million to 1.56 billion by 2026. The market is also being supported by the growing cases of kidney diseases, thus, creating an enhanced demand for drugs like diuretics. The increase in sedentary lifestyles and the changing dietary patterns are one of the major causes of these health conditions. Further, the growing geriatric population and the improving healthcare infrastructures are also contributing to the industry growth. Over the forecast period, the growing R&D activities and the advancements in the field of pharmaceuticals are expected to positively influence the growth of the industry.

 

Key Industry Players in the Global Diuretic Drugs Therapy Market

The report gives a detailed analysis of the following key players in the global diuretic drugs therapy market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Sanofi SA
  • Mylan N.V.
  • Pfizer Inc.
  • Cipla Ltd.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Diuretic Drugs Therapy Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Diuretic Drugs Therapy Historical Market (2016-2020) 
    8.3    Global Diuretic Drugs Therapy Market Forecast (2021-2026)
    8.4    Global Diuretic Drugs Therapy Market by Product
        8.4.1    Thiazide Diuretics Local
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Loop Diuretics
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Potassium-Sparing Diuretics
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Calcium Sparing Diuretics
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2016-2020)
            8.4.4.3    Forecast Trend (2021-2026)
        8.4.5    Osmotic Diuretics
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2016-2020)
            8.4.5.3    Forecast Trend (2021-2026)
        8.4.6    Low Ceiling Diuretics
            8.4.6.1    Market Share
            8.4.6.2    Historical Trend (2016-2020)
            8.4.6.3    Forecast Trend (2021-2026)
        8.4.7    Others
    8.5    Global Diuretic Drugs Therapy Market by Route of Administration
        8.5.1    Oral
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Intravenous
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
    8.6    Global Diuretic Drugs Therapy Market by Application
        8.6.1    Hypertension
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Glaucoma
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Heart Failure
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Kidney Stones
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2016-2020)
            8.6.4.3    Forecast Trend (2021-2026)
        8.6.5    Others
    8.7    Global Diuretic Drugs Therapy Market by Distribution Channel
        8.7.1    Hospital Pharmacies
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Retail Pharmacies
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
        8.7.3    Online
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2016-2020)
            8.7.3.3    Forecast Trend (2021-2026)
        8.7.4    Others
    8.8    Global Diuretic Drugs Therapy Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Sanofi SA
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Mylan N.V.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Pfizer Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Cipla Ltd.  
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Diuretic Drugs Therapy Market: Key Industry Highlights, 2016 and 2026
2.    Global Diuretic Drugs Therapy Historical Market: Breakup by Product (USD Million), 2016-2020
3.    Global Diuretic Drugs Therapy Market Forecast: Breakup by Product (USD Million), 2021-2026
4.    Global Diuretic Drugs Therapy Historical Market: Breakup by Route of Administration (USD Million), 2016-2020
5.    Global Diuretic Drugs Therapy Market Forecast: Breakup by Route of Administration (USD Million), 2021-2026
6.    Global Diuretic Drugs Therapy Historical Market: Breakup by Application (USD Million), 2016-2020
7.    Global Diuretic Drugs Therapy Market Forecast: Breakup by Application (USD Million), 2021-2026
8.    Global Diuretic Drugs Therapy Historical Market: Breakup by Distribution Channel (USD Million), 2016-2020
9.    Global Diuretic Drugs Therapy Market Forecast: Breakup by Distribution Channel (USD Million), 2021-2026
10.    Global Diuretic Drugs Therapy Historical Market: Breakup by Region (USD Million), 2016-2020
11.    Global Diuretic Drugs Therapy Market Forecast: Breakup by Region (USD Million), 2021-2026
12.    North America Diuretic Drugs Therapy Historical Market: Breakup by Country (USD Million), 2016-2020
13.    North America Diuretic Drugs Therapy Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Europe Diuretic Drugs Therapy Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Europe Diuretic Drugs Therapy Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Asia Pacific Diuretic Drugs Therapy Historical Market: Breakup by Country (USD Million), 2016-2020
17.    Asia Pacific Diuretic Drugs Therapy Market Forecast: Breakup by Country (USD Million), 2021-2026
18.    Latin America Diuretic Drugs Therapy Historical Market: Breakup by Country (USD Million), 2016-2020
19.    Latin America Diuretic Drugs Therapy Market Forecast: Breakup by Country (USD Million), 2021-2026
20.    Middle East and Africa Diuretic Drugs Therapy Historical Market: Breakup by Country (USD Million), 2016-2020
21.    Middle East and Africa Diuretic Drugs Therapy Market Forecast: Breakup by Country (USD Million), 2021-2026
22.    Global Diuretic Drugs Therapy Market Structure

Key Questions Answered in the Report

The global diuretic drugs therapy market was supported by the thriving antihypertensive drugs industry, which attained a value of nearly USD 28 billion in 2020.

The antihypertensive drugs industry, which is aiding the growth of the global diuretic drugs therapy market, is projected to grow at a CAGR of 2% between 2021 and 2026.

The antihypertensive drugs market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach about USD 32 billion by 2026, thus, translating the growth of the global diuretic drugs therapy market.

The major drivers of the industry, such as the advancing pharmaceutical sector, increasing geriatric population, increasing sedentary lifestyles, and growing cases of high blood pressure and hypertension, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing investments in R&D activities and the advancements in the pharmaceutical sectors.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific. 

Thiazide diuretics local, loop diuretics, potassium-sparing diuretics, calcium sparing diuretics, osmotic diuretics, and low ceiling diuretics, among others are the significant diuretic drugs therapy products in the industry.

The major routes of administration include oral and intravenous. 

The major applications of the product are hypertension, glaucoma, heart failure, and kidney stones, among others.

The major distribution channels of the product include hospital pharmacies, retail pharmacies, and online, among others.

The key players in the industry are Sanofi SA, Mylan N.V., Pfizer Inc., Cipla Ltd., and others.

Analyst Review

The global diuretic drugs therapy market is being supported by the growth of the antihypertensive drugs industry, which attained a value of nearly USD 28 billion in 2020 driven by the rising prevalence of hypertension and other lifestyle related diseases. Aided by the increasing R&D activities and the growing pharmaceutical sector, the antihypertensive drugs market is expected to witness a further growth in the forecast period of 2021-2026, expanding at a CAGR of 2% to reach a value of USD 32 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product, the diuretic drugs therapy industry can be segmented into thiazide diuretics local, loop diuretics, potassium-sparing diuretics, calcium sparing diuretics, osmotic diuretics, and low ceiling diuretics, among others. On the basis of distribution channels, the industry can be divided into hospital pharmacies, retail pharmacies, and online, among others. The major regional markets for diuretic drugs therapy are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Sanofi SA, Mylan N.V., Pfizer Inc., and Cipla Ltd., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Single User License

$ 3199     $2799
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Five User License

$ 4199     $3799
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Corporate License

$ 5199     $4799
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Xerostomia Treatment Market Report and Forecast 2021-2026


Global Canine Arthritis Treatment Market Report and Forecast 2021-2026



Global Intraocular Melanoma Treatment Market Report and Forecast 2021-2026



NEWSLETTER